549 related articles for article (PubMed ID: 26781311)
1. Targeting hedgehog signaling pathway in pediatric tumors: in vitro evaluation of SMO and GLI inhibitors.
Arnhold V; Boos J; Lanvers-Kaminsky C
Cancer Chemother Pharmacol; 2016 Mar; 77(3):495-505. PubMed ID: 26781311
[TBL] [Abstract][Full Text] [Related]
2. Targeting the hedgehog signal transduction pathway at the level of GLI inhibits neuroblastoma cell growth in vitro and in vivo.
Wickström M; Dyberg C; Shimokawa T; Milosevic J; Baryawno N; Fuskevåg OM; Larsson R; Kogner P; Zaphiropoulos PG; Johnsen JI
Int J Cancer; 2013 Apr; 132(7):1516-24. PubMed ID: 22949014
[TBL] [Abstract][Full Text] [Related]
3. Targeting of the Hedgehog signal transduction pathway suppresses survival of malignant pleural mesothelioma cells in vitro.
You M; Varona-Santos J; Singh S; Robbins DJ; Savaraj N; Nguyen DM
J Thorac Cardiovasc Surg; 2014 Jan; 147(1):508-16. PubMed ID: 24094913
[TBL] [Abstract][Full Text] [Related]
4. Small-molecule modulators of the Sonic Hedgehog signaling pathway.
Stanton BZ; Peng LF
Mol Biosyst; 2010 Jan; 6(1):44-54. PubMed ID: 20024066
[TBL] [Abstract][Full Text] [Related]
5. The presence of primary cilia in cancer cells does not predict responsiveness to modulation of smoothened activity.
Spann AL; Yuan K; Goliwas KF; Steg AD; Kaushik DD; Kwon YJ; Frost AR
Int J Oncol; 2015 Jul; 47(1):269-79. PubMed ID: 25997440
[TBL] [Abstract][Full Text] [Related]
6. Targeting the hedgehog-glioma-associated oncogene homolog pathway inhibits bleomycin-induced lung fibrosis in mice.
Moshai EF; Wémeau-Stervinou L; Cigna N; Brayer S; Sommé JM; Crestani B; Mailleux AA
Am J Respir Cell Mol Biol; 2014 Jul; 51(1):11-25. PubMed ID: 24450438
[TBL] [Abstract][Full Text] [Related]
7. Gant61 ameliorates CCl
Jiayuan S; Junyan Y; Xiangzhen W; Zuping L; Jian N; Baowei H; Lifang J
Toxicol Appl Pharmacol; 2020 Jan; 387():114853. PubMed ID: 31816328
[TBL] [Abstract][Full Text] [Related]
8. Pharmacological inhibition of the Hedgehog pathway prevents human rhabdomyosarcoma cell growth.
Kawabata N; Ijiri K; Ishidou Y; Yamamoto T; Nagao H; Nagano S; Maeda S; Komiya S; Setoguchi T
Int J Oncol; 2011 Oct; 39(4):899-906. PubMed ID: 21674124
[TBL] [Abstract][Full Text] [Related]
9. The GLI genes as the molecular switch in disrupting Hedgehog signaling in colon cancer.
Mazumdar T; DeVecchio J; Agyeman A; Shi T; Houghton JA
Oncotarget; 2011 Aug; 2(8):638-45. PubMed ID: 21860067
[TBL] [Abstract][Full Text] [Related]
10. Involvement and targeted intervention of dysregulated Hedgehog signaling in osteosarcoma.
Lo WW; Wunder JS; Dickson BC; Campbell V; McGovern K; Alman BA; Andrulis IL
Cancer; 2014 Feb; 120(4):537-47. PubMed ID: 24151134
[TBL] [Abstract][Full Text] [Related]
11. Regulation of DNA damage following termination of Hedgehog (HH) survival signaling at the level of the GLI genes in human colon cancer.
Agyeman A; Mazumdar T; Houghton JA
Oncotarget; 2012 Aug; 3(8):854-68. PubMed ID: 23097684
[TBL] [Abstract][Full Text] [Related]
12. Hedgehog-signaling is upregulated in non-producing human adrenal adenomas and antagonism of hedgehog-signaling inhibits proliferation of NCI-H295R cells and an immortalized primary human adrenal cell line.
Werminghaus P; Haase M; Hornsby PJ; Schinner S; Schott M; Malendowicz LK; Lammers BJ; Goretzki PE; Müller-Mattheis V; Markus Giessing ; Willenberg HS
J Steroid Biochem Mol Biol; 2014 Jan; 139():7-15. PubMed ID: 24063979
[TBL] [Abstract][Full Text] [Related]
13. Smoothened as a new therapeutic target for human osteosarcoma.
Hirotsu M; Setoguchi T; Sasaki H; Matsunoshita Y; Gao H; Nagao H; Kunigou O; Komiya S
Mol Cancer; 2010 Jan; 9():5. PubMed ID: 20067614
[TBL] [Abstract][Full Text] [Related]
14. Hedgehog signaling drives cellular survival in human colon carcinoma cells.
Mazumdar T; DeVecchio J; Shi T; Jones J; Agyeman A; Houghton JA
Cancer Res; 2011 Feb; 71(3):1092-102. PubMed ID: 21135115
[TBL] [Abstract][Full Text] [Related]
15. Hedgehog-GLI signaling inhibition suppresses tumor growth in squamous lung cancer.
Huang L; Walter V; Hayes DN; Onaitis M
Clin Cancer Res; 2014 Mar; 20(6):1566-75. PubMed ID: 24423612
[TBL] [Abstract][Full Text] [Related]
16. Gli-1 expression is associated with lymph node metastasis and tumor progression in esophageal squamous cell carcinoma.
Mori Y; Okumura T; Tsunoda S; Sakai Y; Shimada Y
Oncology; 2006; 70(5):378-89. PubMed ID: 17179732
[TBL] [Abstract][Full Text] [Related]
17. Widespread Expression of Hedgehog Pathway Components in a Large Panel of Human Tumor Cells and Inhibition of Tumor Growth by GANT61: Implications for Cancer Therapy.
Réda J; Vachtenheim J; Vlčková K; Horák P; Vachtenheim J; Ondrušová L
Int J Mol Sci; 2018 Sep; 19(9):. PubMed ID: 30201866
[TBL] [Abstract][Full Text] [Related]
18. Targeting GLI factors to inhibit the Hedgehog pathway.
Infante P; Alfonsi R; Botta B; Mori M; Di Marcotullio L
Trends Pharmacol Sci; 2015 Aug; 36(8):547-58. PubMed ID: 26072120
[TBL] [Abstract][Full Text] [Related]
19. Suppression of GLI sensitizes medulloblastoma cells to mitochondria-mediated apoptosis.
Lin Z; Li S; Sheng H; Cai M; Ma LY; Hu L; Xu S; Yu LS; Zhang N
J Cancer Res Clin Oncol; 2016 Dec; 142(12):2469-2478. PubMed ID: 27601167
[TBL] [Abstract][Full Text] [Related]
20. In vitro and in vivo inhibition of breast cancer cell growth by targeting the Hedgehog/GLI pathway with SMO (GDC-0449) or GLI (GANT-61) inhibitors.
Benvenuto M; Masuelli L; De Smaele E; Fantini M; Mattera R; Cucchi D; Bonanno E; Di Stefano E; Frajese GV; Orlandi A; Screpanti I; Gulino A; Modesti A; Bei R
Oncotarget; 2016 Feb; 7(8):9250-70. PubMed ID: 26843616
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
